Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...
MONTCO.Today on MSN1d
Audubon’s Globus Medical Makes Game-Changing AcquisitionAudubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Zacks.com on MSN3d
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...
From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.
The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback